Heuman, Douglas M.

Altered profile of human gut microbiome is associated with cirrhosis and its complications

Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 1,099

Linkage of gut microbiome with cognition in hepatic encephalopathy

Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 547

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

Bajaj, J. S., Heuman, D. M., Sanyal, A. J., Hylemon, P. B., Sterling, R. K., Stravitz, R. T., Fuchs, M., Ridlon, J. M., Daita, K., Monteith, P., et al. (2013) · PLoS ONE

Liver Disease and TransplantationGut microbiota and health

Cited by 430

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 325

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

Bajaj, J. S., Cox, I. J., Betrapally, N. S., Heuman, D. M., Schubert, M. L., Ratneswaran, M., Hylemon, P. B., White, M. B., Daita, K., Noble, N. A., et al. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 143

Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort

Bajaj, J. S., Idilman, R., Mabudian, L., Hood, M., Fagan, A., Turan, D., White, M. B., Karakaya, F., Wang, J., Atalay, R., et al. (2018) · Hepatology

Gut microbiota and healthLiver Disease and Transplantation

Cited by 125

Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with rifaximin in cirrhosis: implications for the gut-liver-brain axis

Ahluwalia, V., Wade, J. B., Heuman, D. M., Hammeke, T. A., Sanyal, A. J., Sterling, R. K., Stravitz, R. T., Luketic, V., Siddiqui, M. S., Puri, P., et al. (2014) · Metabolic Brain Disease

Liver Disease and TransplantationAdvanced MRI Techniques and Applications

Cited by 92

PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis: PROMIS tools for quality of life assessment in cirrhosis

Bajaj, J. S., Thacker, L. R., Wade, J. B., Sanyal, A. J., Heuman, D. M., Sterling, R. K., Gibson, D. P., Stravitz, R. T., Puri, P., Fuchs, M., et al. (2011) · Alimentary Pharmacology & Therapeutics

Psychometric Methodologies and TestingLiver Disease and Transplantation

Cited by 83

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients

Bajaj, J. S., Sterling, R. K., Betrapally, N. S., Nixon, D. E., Fuchs, M., Daita, K., Heuman, D. M., Sikaroodi, M., Hylemon, P. B., White, M. B., et al. (2016) · Alimentary Pharmacology & Therapeutics

Gut microbiota and healthHepatitis C virus research

Cited by 63